(Q36086716)
Statements
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study (English)
Ernst-Wilhelm Radue
Eva Havrdova
Dusan Stefoski
Till Sprenger
Stanley Cohan
Kimberly Umans
Steven J Greenberg
Gulden Ozen
Jacob Elkins
1 reference
1 reference